Search clinical trials for: V920 High-dose Lot
Total 3656 results
-
Veradermics, Inc.RecruitingWarts | Common Wart | Verruca VulgarisUnited States
-
Institut Pasteur de LilleCompleted
-
GeneScience Pharmaceuticals Co., Ltd.The First Affiliated Hospital with Nanjing Medical University; Tongji Hospital and other collaboratorsUnknown
-
Mitsubishi Tanabe Pharma CorporationCompletedSystemic Lupus ErythematosusJapan
-
Boehringer IngelheimCompleted
-
Universitat de LleidaPharmactive Biotech Products S.L.URecruiting
-
HK inno.N CorporationRecruitingCOVID-19Korea, Republic of
-
Sclnow Biotechnology Co., Ltd.RecruitingOsteoarthritis, KneeChina
-
Regeneron PharmaceuticalsActive, not recruitingGeneralized LipodystrophyUnited States, Peru, Russian Federation, Turkey
-
Milton S. Hershey Medical CenterCompleted
-
Kissei Pharmaceutical Co., Ltd.CompletedSpinocerebellar DegenerationJapan
-
Kissei Pharmaceutical Co., Ltd.CompletedSpinocerebellar DegenerationJapan
-
Merck Sharp & Dohme LLCWithdrawn
-
Tasly Pharmaceutical Group Co., LtdRecruitingChronic Heart Failure With Reduced Ejection FractionChina
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Tasly Pharmaceutical Group Co., LtdRecruiting
-
Sean LiuActive, not recruitingSARS-CoV-2United States
-
AkesoTerminatedOvarian Neoplasms | Ovarian Cancer | Recurrent Ovarian Carcinoma | Relapsed Ovarian CancerChina
-
Trinomab Biotech Co., Ltd.Completed
-
Fu-Sheng WangUnknownHuman Immunodeficiency Virus | Disorder of Immune ReconstitutionChina
-
PfizerCompletedRespiratory Tract Diseases | Lung Diseases | Pulmonary Disease, Chronic Obstructive | COPD | Chronic Obstructive Airway DiseaseGermany
-
Hong Kong Baptist UniversityCompleted
-
Pharvaris Netherlands B.V.Active, not recruitingHereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditionsUnited States, Poland, Germany, Austria, Bulgaria, Canada, Ireland, Italy, United Kingdom
-
Reistone Biopharma Company LimitedTerminated
-
Lisata Therapeutics, Inc.California Institute for Regenerative Medicine (CIRM); Sanford HealthCompletedDiabetes MellitusUnited States
-
Combioxin SACompletedPneumonia | Pneumococcal InfectionsFrance, Belgium
-
Maternal and Child Health Hospital of FoshanCompleted
-
Umeå UniversityMedtronicCompletedCardiopulmonary Bypass | Bleeding Disorder | Platelet Dysfunction Due to Drugs | Platelet DisorderSweden
-
Unilever R&DCompleted
-
Santen Inc.Completed
-
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Shanghai Public Health Clinical Center; Beijing Simoonrecord Pharmaceutical...Completed
-
Charleston Laboratories, IncCompleted
-
Virchow GroupAdociaCompleted
-
Dr. Falk Pharma GmbHCompletedCrohn´s DiseaseGermany
-
Seoul National University HospitalGreen Cross Corporation; LSK Global Pharma Services Co. Ltd.Completed
-
ReiThera SrlCompletedRespiratory Syncytial Virus InfectionsUnited Kingdom
-
Sylentis, S.A.CompletedChoroidal Neovascularization | Safety, Tolerability and Pharmacokinetic Profile in Healthy VolunteersSpain
-
Washington University School of MedicineNational Institutes of Health (NIH); AmgenCompletedType Two Diabetes MellitusUnited States
-
Swedish Orphan BiovitrumCompletedChronic GoutUnited States, Serbia, Georgia, Ukraine, Russian Federation
-
Instituto de Investigación Sanitaria de la Fundación...Clinica Universidad de Navarra, Universidad de Navarra; Hospital Universitario... and other collaboratorsActive, not recruitingDiabetic Foot | Limb IschemiaSpain
-
Maternal and Child Health Hospital of FoshanWithdrawn
-
Helixmith Co., Ltd.CompletedCritical Limb IschemiaUnited States, Korea, Republic of
-
Kissei Pharmaceutical Co., Ltd.CompletedSpinocerebellar DegenerationJapan
-
Kolon Life ScienceCompletedDegenerative ArthritisKorea, Republic of
-
Beacon TherapeuticsEnrolling by invitationX-Linked Retinitis PigmentosaUnited States
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Argentina, Australia, Brazil, Bulgaria, Canada, Colombia, Denmark, Estonia, Hungary, Italy, Lebanon, Malaysia, Mexico, Peru, Philippines, Poland, Romania, Russian Federation, Spain, Sweden, Taiwan
-
The University of Texas Health Science Center,...TerminatedRecurrent C. Difficile InfectionUnited States
-
Boehringer IngelheimCompletedArthritis, Rheumatoid
-
University Hospital, Basel, SwitzerlandRecruitingEffects of Intravenous [Pyr1]Apelin-13 on Healthy Volunteers With Artificially Induced SIAD (ESCAPE)Hyponatremia | SIAD - Syndrome of Inappropriate AntidiuresisSwitzerland